论文部分内容阅读
我院自1956年起使用了对氨柳酸钠静脉点滴疗法,并曾于1958年总结报道过一次。最近6年来,更对重度肺结核复治的病人使用了对氨柳酸钠静脉点滴合并疗法,收到了良好的效果。现仅就7,000例住院病人中的重度复治病例,按同时期、同病型、同病变范围(三个肺野以上)、代偿机能相似、合并疗法相同、而且药物用量相等的等等条件下选出374例,按统计学分层抽签法选例,抽得静脉点滴组和口服组(浸润型两组各85例,慢性纤维空洞型两组各55例,共280例)进行疗效的对此分析。
Our hospital has used intravenous drip therapy of sodium salicylate since 1956, and once reported it in 1958. In the last 6 years, even more patients with severe pulmonary tuberculosis were treated with intravenous sodium salicylate combination therapy, and received good results. Only in the case of severe re-treatment of 7,000 inpatients, according to the same period, the same type, the same range of lesions (more than three lung fields), compensatory function similar to the same combination therapy, and the same dosage of drugs and so on A total of 374 cases were selected. According to the statistical stratified lottery selection method, the curative effect was compared between intravenous drip group and oral group (85 infiltrative group and 55 chronic suppurative group, 280 cases in total) Analysis of this.